七氟醚对糖尿病患者神经肌肉阻滞影响的临床研究(附30例分析) 被引量：1

下载PDF

导出

摘要目的观察七氟醚麻醉下维库溴铵对糖尿病患者神经肌肉阻滞时-效的影响,以期评价七氟醚对糖尿病患者肌松的影响。方法选择ASAⅡ～Ⅲ级择期手术气管插管全麻的糖尿病患者30例,随机分为C组(对照组)和S组(七氟醚组),各15例。C组患者以异丙酚和芬太尼维持麻醉,S组患者以1．7％七氟醚和芬太尼维持麻醉。当给予维库溴胺0．1 mg·kg-1静推后,观察两组患者从给维库溴铵到T1、T2、T3、T4出现时间和TOF值;并用T1／T对照值来评价肌肉阻滞程度。结果S组T1、T2、T3、T4出现时间长于C组,两者相比有显著性差异(P<0．05),给予维库溴铵后70～120 min,S组T／T对照值明显低于C组,有显著性差异(P<0．05),给予维库溴铵后80～120 min,S组的TOF明显低于C组,有显著性差异(P<0．05)。结论七氟醚麻醉下,糖尿病患者的T1、T2、T3、T4恢复时间明显长于全凭静脉麻醉,T1／T对照值和TOF低于全凭静脉麻醉。因此,糖尿病患者在复合七氟醚麻醉时,手术过程需要减少肌松药用量,适当延长给予肌松药的间隔时间。

作者林绍立林梁陈振毅

机构地区福建医科大学附属厦门市第一医院麻醉科

出处《福建医药杂志》 CAS 2006年第3期55-56,共2页 Fujian Medical Journal

关键词七氟醚维库溴胺神经肌肉接头糖尿病

分类号 R614.1 [医药卫生—麻醉学]

引文网络
相关文献

参考文献12

1Saitoh Y,Toyooka H,Amaha K,et al.Recovery of posttetanic twitch and train-of-four responses after administration of vecuronium with different enhalation anesthetics and neuroleptanaesthesia.Br J Anaesth,1993,70:402.
2林成新,蒋宗滨,覃忠,胡振快,谭冠先.糖尿病病人术中维库溴铵肌松效应的变化[J].中华麻醉学杂志,2003,23(8):628-629. 被引量：6
3罗伟,沈伯雄.糖尿病人持续输注罗库溴铵后残余肌松的变化[J].上海第二医科大学学报,2004,24(11):958-960. 被引量：4
4叶任高陆再英.内科学.第5版[M].北京:人民卫生出版社,2001.913.
5陈丽,冉祥凯.糖尿病神经病变与醛糖还原酶抑制剂[J].国外医学（内分泌学分册）,1996,16(4):188-190. 被引量：12
6Savares JJ,Caldwell JE,Lien CA.Pharmacology of muscle relaxants and their antagonists.Miller RD,Ed.Anesthesia.5th ed.Philadelphia:Churchill Livingstone,2000:471-472.
7Eady JI,Cobbs KF.Diabetic muscle infarction.J South Orthop Assoc,1997,6 (3):250-255.
8杨昌明,周玉,肖少华.维库溴铵对糖尿病患者神经肌肉阻滞的影响[J].医药导报,2005,24(9):790-791. 被引量：4
9Dilger JP,Vidal AM,Mody HI,et al.Evidence for direct action of general anesthesia on an ion channel protive.Anesthesiology,1994,81 (4):431-432
10Kennedy R,Galindo A.Neuromuscular transmisson in a mammalian preparation during exposure to enflurane.Anesthesiology,1975,42:432.

二级参考文献13

1陈丽,冉祥凯.糖尿病神经病变与醛糖还原酶抑制剂[J].国外医学（内分泌学分册）,1996,16(4):188-190. 被引量：12
2Feldman S 主编吴新民译.神经肌肉阻滞：第1版[M].北京:科学出版社,1998.14.
3Kimura M, Kimura I, Nojima H, et al, Diabetes mellitus - induced hypersensitivity of mouse skeletal muscles to acetylcholine andsuccinylcholine. Jpn J Pharmacol, 1986, 40: 251-256.
4Minker E, Kae P, Kohai M. Effect of muscle relaxants on the motor endplate of diabetic and glucocorticoid pretreated rats. Acta Physiol Hung, 1986,67 : 257-266.
5Atallah MM, Daif AA, Saied MM, et al. Neuromuscular blocking activity of tubocurarine in patients with diabetes menitus. Br J Anaesth, 1992,68:567-569.
6Yue DK, Brooks B. The role of aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy. Med J Aust, 1993,159:76-78
7Fahim MA, Hasan MY, Alshuaib WB. Early morphological remodeling of neuromuscular junction in a murine model of diabetes. J Appl Physiol,2000, 89: 2235-2240.
8Hayes AH,Mirakhur RK,Breslin DS,et al.Postoperative residual block after intermediate-acting neuromuscular blocking drugs[J].Anaesthesia,2001,56(4):312-318.
9Saitoh Y,Kaneda K,Hattori H,et al.Monitoring of neuromuscular block after administration of vecuronium in patients with diabetes mellitus[J].Br J Anaesth,2003,90(4):480-486.
10Khuenl-Brady KS,Sparr H.Clinical pharmacokinetics of rocuronium bromide[J].Clin Pharmacokinet,1996;31:174-183.